JP2021535896A5 - - Google Patents

Info

Publication number
JP2021535896A5
JP2021535896A5 JP2020571610A JP2020571610A JP2021535896A5 JP 2021535896 A5 JP2021535896 A5 JP 2021535896A5 JP 2020571610 A JP2020571610 A JP 2020571610A JP 2020571610 A JP2020571610 A JP 2020571610A JP 2021535896 A5 JP2021535896 A5 JP 2021535896A5
Authority
JP
Japan
Prior art keywords
composition according
flt
antibody
antigen
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020571610A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021535896A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/038470 external-priority patent/WO2019246521A1/en
Publication of JP2021535896A publication Critical patent/JP2021535896A/ja
Publication of JP2021535896A5 publication Critical patent/JP2021535896A5/ja
Priority to JP2023099270A priority Critical patent/JP2023108031A/ja
Pending legal-status Critical Current

Links

JP2020571610A 2018-06-22 2019-06-21 気管支肺異形成症の治療における抗Flt−1抗体 Pending JP2021535896A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023099270A JP2023108031A (ja) 2018-06-22 2023-06-16 気管支肺異形成症の治療における抗Flt-1抗体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862688541P 2018-06-22 2018-06-22
US62/688,541 2018-06-22
PCT/US2019/038470 WO2019246521A1 (en) 2018-06-22 2019-06-21 Anti-flt-1 antibodies in treating bronchopulmonary dysplasia

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023099270A Division JP2023108031A (ja) 2018-06-22 2023-06-16 気管支肺異形成症の治療における抗Flt-1抗体

Publications (2)

Publication Number Publication Date
JP2021535896A JP2021535896A (ja) 2021-12-23
JP2021535896A5 true JP2021535896A5 (https=) 2022-06-28

Family

ID=67211919

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020571610A Pending JP2021535896A (ja) 2018-06-22 2019-06-21 気管支肺異形成症の治療における抗Flt−1抗体
JP2023099270A Pending JP2023108031A (ja) 2018-06-22 2023-06-16 気管支肺異形成症の治療における抗Flt-1抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023099270A Pending JP2023108031A (ja) 2018-06-22 2023-06-16 気管支肺異形成症の治療における抗Flt-1抗体

Country Status (5)

Country Link
US (1) US20210261672A1 (https=)
EP (1) EP3810652A1 (https=)
JP (2) JP2021535896A (https=)
CN (1) CN113260628A (https=)
WO (1) WO2019246521A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026072909A2 (en) * 2024-09-27 2026-04-02 Amgen Inc. Flt1 binding proteins and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2011005824A0 (en) * 2009-01-26 2011-08-31 Intermune Inc Methods for treating acute myocardial infarctions and associated disorders.
MX391847B (es) * 2015-04-07 2025-03-21 Takeda Pharmaceuticals Co Anticuerpos anti-flt-1 para tratar displasia broncopulmonar.
US10711065B2 (en) 2015-04-07 2020-07-14 Shire Human Genetic Therapies, Inc. Anti-FLT-1 antibodies in treating bronchopulmonary dysplasia

Similar Documents

Publication Publication Date Title
EP3983439A1 (en) Use of an activatable anti-pdl1 antibody and an anti-ctla-4 antibody in a combination therapy for the treatment of cancer
JP2025084976A5 (https=)
JP2020536097A5 (https=)
WO2011103700A1 (zh) 一种全人源抗her2单克隆抗体、其制备方法及用途
JP2021526534A5 (https=)
JP2008518936A5 (https=)
WO2001087334A1 (en) Aromatase inhibitors and monoclonal anti-her2 antibodies as antitumors agents
JP2010520290A5 (https=)
KR102337599B1 (ko) 벤랄리주맙을 이용하여 천식 환자에서 강제 호기량을 증가시키는 방법
JP2022531408A5 (https=)
JP2021525718A5 (https=)
JP2018515442A5 (https=)
JP2025508867A5 (https=)
JP2020511494A5 (https=)
JP2022542472A5 (https=)
JP2021535896A5 (https=)
JP2020504135A5 (https=)
JP2023545084A5 (https=)
JP2024542823A5 (https=)
JP7093940B2 (ja) 全身性強皮症治療用医薬組成物
JP2024521105A5 (https=)
JP2018517667A5 (https=)
CN119454937A (zh) 抗b7h3抗体-药物偶联物治疗癌症的方法
JP2024177399A (ja) 呼吸器疾患の治療のための汎elr+cxcケモカイン抗体
CN119894516A (zh) 用于治疗晚期实体瘤的组合物和方法